Bank of New York Mellon’s AMAG Pharmaceuticals, Inc. AMAG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q4
Sell
-359,863
Closed -$3.38M 4285
2020
Q3
$3.38M Sell
359,863
-31,266
-8% -$294K ﹤0.01% 2415
2020
Q2
$2.99M Sell
391,129
-6,416
-2% -$49.1K ﹤0.01% 2462
2020
Q1
$2.46M Sell
397,545
-24,540
-6% -$152K ﹤0.01% 2452
2019
Q4
$5.14M Buy
422,085
+4,058
+1% +$49.4K ﹤0.01% 2329
2019
Q3
$4.83M Sell
418,027
-5,897
-1% -$68.1K ﹤0.01% 2306
2019
Q2
$4.24M Buy
423,924
+12,063
+3% +$121K ﹤0.01% 2415
2019
Q1
$5.31M Sell
411,861
-5,497
-1% -$70.8K ﹤0.01% 2305
2018
Q4
$6.34M Sell
417,358
-1,863
-0.4% -$28.3K ﹤0.01% 2155
2018
Q3
$8.39M Buy
419,221
+11,176
+3% +$224K ﹤0.01% 2127
2018
Q2
$7.96M Sell
408,045
-12,880
-3% -$251K ﹤0.01% 2146
2018
Q1
$8.48M Sell
420,925
-216,823
-34% -$4.37M ﹤0.01% 2068
2017
Q4
$8.45M Sell
637,748
-71,391
-10% -$946K ﹤0.01% 2069
2017
Q3
$13.1M Sell
709,139
-8,114
-1% -$150K ﹤0.01% 1842
2017
Q2
$13.2M Sell
717,253
-7,944
-1% -$146K ﹤0.01% 1818
2017
Q1
$16.4M Buy
725,197
+277,052
+62% +$6.25M ﹤0.01% 1663
2016
Q4
$15.6M Sell
448,145
-22,770
-5% -$792K ﹤0.01% 1697
2016
Q3
$11.5M Sell
470,915
-17,266
-4% -$423K ﹤0.01% 1800
2016
Q2
$11.7M Buy
488,181
+460
+0.1% +$11K ﹤0.01% 1765
2016
Q1
$11.4M Buy
487,721
+243,186
+99% +$5.69M ﹤0.01% 1757
2015
Q4
$7.38M Buy
244,535
+56,451
+30% +$1.7M ﹤0.01% 1997
2015
Q3
$7.47M Buy
188,084
+7,811
+4% +$310K ﹤0.01% 2010
2015
Q2
$12.4M Buy
180,273
+29,256
+19% +$2.02M ﹤0.01% 1839
2015
Q1
$8.25M Buy
151,017
+12,000
+9% +$656K ﹤0.01% 2042
2014
Q4
$5.93M Sell
139,017
-21,358
-13% -$910K ﹤0.01% 2232
2014
Q3
$5.12M Buy
160,375
+44,319
+38% +$1.41M ﹤0.01% 2306
2014
Q2
$2.41M Sell
116,056
-3,594
-3% -$74.5K ﹤0.01% 2792
2014
Q1
$2.32M Sell
119,650
-1,738
-1% -$33.6K ﹤0.01% 2786
2013
Q4
$2.95M Buy
121,388
+2,556
+2% +$62.1K ﹤0.01% 2633
2013
Q3
$2.55M Buy
118,832
+2,532
+2% +$54.4K ﹤0.01% 2691
2013
Q2
$2.59M Buy
+116,300
New +$2.59M ﹤0.01% 2619